Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Christopher K. Surratt

A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets

Frontiers in Neurology
Neurology
2015English

Related publications

Cannabinoid CB1 Receptor-Interacting Proteins: Novel Targets for Central Nervous System Drug Discovery?

British Journal of Pharmacology
Pharmacology
2010English

Novel Role for Apolipoprotein E in the Central Nervous System

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

In Silico Approaches for Fragment-Based Drug Design

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2010English

Drugs Acting on Central Nervous System (CNS) Targets as Leads for Non-CNS Targets

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2014English

Novel Receptor Targets for Production and Action of Allopregnanolone in the Central Nervous System: A Focus on Pregnane Xenobiotic Receptor

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2014English

APRIL and BAFF: Novel Biomarkers for Central Nervous System Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Fragment-Based Drug Design and Identification of HJC0123 , a Novel Orally Bioavailable STAT3 Inhibitor for Cancer Therapy

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2013English

Discovery of Novel KRAS-PDE Inhibitors by Fragment-Based Drug Design

English

Synaptic Targets of 9-Tetrahydrocannabinol in the Central Nervous System

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy